Biomarkers cover a broad spectrum: from body temperature and blood count to the expression of certain genes in cancer cells. MR-based biomarkers are particularly elegant because they are non-invasive, i.e., they do not require a biopsy or blood sample.

ASL has the potential to improve diagnosis and treatment monitoring in Alzheimer’s Disease, especially for older adults with cardiovascular risk factors.

Precise, individual diagnosis of dementia, even in smaller practices and clinics without a research background, is our vision. Artificial intelligence is predestined to support physicians in this work.

Whether neuroimaging, real-time image analysis or deep learning – research is the mainspring of mediri. And the basis of the competence that we make available to our customers in clinical trials.

Technical contact with our customers is particularly important to us. That is why we pay special attention to ensuring a qualified contact person is always available.